Macrophage polarization in tissue fibrosis.

Cardiac fibrosis Kidney fibrosis Liver fibrosis Lung fibrosis Macrophage polarization Myofibroblasts Skin fibrosis Type 2 macrophage

Journal

PeerJ
ISSN: 2167-8359
Titre abrégé: PeerJ
Pays: United States
ID NLM: 101603425

Informations de publication

Date de publication:
2023
Historique:
received: 22 02 2023
accepted: 23 08 2023
medline: 23 10 2023
pubmed: 18 10 2023
entrez: 18 10 2023
Statut: epublish

Résumé

Fibrosis can occur in all major organs with relentless progress, ultimately leading to organ failure and potentially death. Unfortunately, current clinical treatments cannot prevent or reverse tissue fibrosis. Thus, new and effective antifibrotic therapeutics are urgently needed. In recent years, a growing body of research shows that macrophages are involved in fibrosis. Macrophages are highly heterogeneous, polarizing into different phenotypes. Some studies have found that regulating macrophage polarization can inhibit the development of inflammation and cancer. However, the exact mechanism of macrophage polarization in different tissue fibrosis has not been fully elucidated. This review will discuss the major signaling pathways relevant to macrophage-driven fibrosis and profibrotic macrophage polarization, the role of macrophage polarization in fibrosis of lung, kidney, liver, skin, and heart, potential therapeutics targets, and investigational drugs currently in development, and hopefully, provide a useful review for the future treatment of fibrosis.

Identifiants

pubmed: 37849830
doi: 10.7717/peerj.16092
pii: 16092
pmc: PMC10578305
doi:

Types de publication

Review Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e16092

Informations de copyright

©2023 Yang et al.

Déclaration de conflit d'intérêts

The authors declare there are no competing interests.

Références

Immunopharmacol Immunotoxicol. 2020 Dec;42(6):556-563
pubmed: 32811220
Ren Fail. 2016 Nov;38(10):1711-1716
pubmed: 26984259
Cell. 1997 Jun 27;89(7):1165-73
pubmed: 9215638
Annu Rev Physiol. 2011;73:413-35
pubmed: 21054168
Curr Opin Rheumatol. 2004 Nov;16(6):733-8
pubmed: 15577612
PeerJ. 2022 Sep 29;10:e14053
pubmed: 36196399
Braz J Med Biol Res. 2021 Jul 23;54(8):e11184
pubmed: 34320121
JHEP Rep. 2022 Feb 01;4(4):100444
pubmed: 35252828
Front Cardiovasc Med. 2022 Jan 17;8:639476
pubmed: 35111821
PLoS One. 2016 Mar 02;11(3):e0150607
pubmed: 26934748
Mol Biol Rep. 2021 Sep;48(9):6443-6456
pubmed: 34398425
J Am Soc Nephrol. 2008 Dec;19(12):2282-7
pubmed: 18987304
Annu Rev Pathol. 2020 Jan 24;15:123-147
pubmed: 31530089
Nat Immunol. 2013 Oct;14(10):986-95
pubmed: 24048120
Front Physiol. 2018 May 07;9:473
pubmed: 29867533
J Exp Med. 2018 Feb 5;215(2):423-440
pubmed: 29339450
Dev Cell. 2009 Jul;17(1):9-26
pubmed: 19619488
Cell Biol Int. 2017 Sep;41(9):960-968
pubmed: 28493530
Int Immunopharmacol. 2022 Dec;113(Pt A):109424
pubmed: 36461589
Cells. 2023 Apr 26;12(9):
pubmed: 37174654
FASEB J. 2023 May;37(5):e22901
pubmed: 37002884
Hepatology. 2018 May;67(5):1754-1767
pubmed: 28833331
Kidney Int. 2011 Nov;80(9):915-925
pubmed: 21814171
Biochem Biophys Res Commun. 2022 Dec 25;636(Pt 2):119-127
pubmed: 36368154
JCI Insight. 2018 May 3;3(9):
pubmed: 29720573
Nat Rev Nephrol. 2015 Apr;11(4):233-44
pubmed: 25584804
Oncotarget. 2016 Feb 23;7(8):8809-22
pubmed: 26684242
Biol Pharm Bull. 2015;38(10):1464-9
pubmed: 26424011
Int Immunopharmacol. 2023 May;118:110070
pubmed: 37003186
Nat Rev Nephrol. 2011 Oct 18;7(12):684-96
pubmed: 22009250
Int J Mol Sci. 2022 Apr 01;23(7):
pubmed: 35409294
Clin Respir J. 2022 Feb;16(2):84-96
pubmed: 35001525
Theranostics. 2021 Jan 1;11(3):1192-1206
pubmed: 33391530
Eur J Clin Invest. 2022 Aug;52(8):e13791
pubmed: 35441708
Dev Cell. 2002 Dec;3(6):765-78
pubmed: 12479803
Eur J Pharmacol. 2018 Feb 5;820:65-76
pubmed: 29229532
Nat Commun. 2021 Dec 8;12(1):7259
pubmed: 34880239
Chem Biol Drug Des. 2018 Apr;91(4):933-941
pubmed: 29250925
J Pathol. 2017 Jan;241(1):80-90
pubmed: 27763657
Clin Res Hepatol Gastroenterol. 2015 Sep;39 Suppl 1:S24-8
pubmed: 26189984
FASEB J. 2016 Jan;30(1):129-40
pubmed: 26324850
Am J Respir Crit Care Med. 2011 Sep 1;184(5):569-81
pubmed: 21680953
Int Immunopharmacol. 2021 Apr;93:107396
pubmed: 33540244
Nature. 2019 Nov;575(7783):512-518
pubmed: 31597160
J Immunol. 2010 Apr 1;184(7):3964-77
pubmed: 20176743
Fibrogenesis Tissue Repair. 2012 Jun 06;5(Suppl 1):S5
pubmed: 23259712
Oncotarget. 2017 Nov 23;8(65):109238-109246
pubmed: 29312604
Nat Commun. 2017 Feb 09;8:14361
pubmed: 28181491
J Biomed Sci. 2021 May 9;28(1):36
pubmed: 33966637
Metabolism. 2016 Feb;65(2):30-40
pubmed: 26773927
Semin Liver Dis. 2010 Aug;30(3):245-57
pubmed: 20665377
Oncogene. 2006 Apr 20;25(17):2520-30
pubmed: 16474852
Arthritis Res Ther. 2018 Mar 15;20(1):46
pubmed: 29544542
Int Immunol. 2016 May;28(5):233-43
pubmed: 26647405
J Histochem Cytochem. 2016 Mar;64(3):157-67
pubmed: 26747705
Development. 2012 Jun;139(12):2139-49
pubmed: 22573622
Lancet Respir Med. 2021 Sep;9(9):1065-1076
pubmed: 34331867
JAMA. 2023 May 9;329(18):1589-1602
pubmed: 37159031
Nat Rev Rheumatol. 2011 Oct 25;8(1):42-54
pubmed: 22025123
Nature. 2017 Jan 5;541(7635):96-101
pubmed: 28002407
Sci Rep. 2017 Aug 24;7(1):9371
pubmed: 28839221
Nat Rev Immunol. 2014 Jun;14(6):392-404
pubmed: 24854589
Proc Natl Acad Sci U S A. 2013 Jan 22;110(4):1440-5
pubmed: 23302695
Rheumatology (Oxford). 2023 Feb 6;62(SI):SI114-SI124
pubmed: 35946522
Nature. 2020 Nov;587(7835):555-566
pubmed: 33239795
J Biol Chem. 2007 Jul 27;282(30):22089-101
pubmed: 17513865
Front Immunol. 2022 Aug 03;13:940645
pubmed: 35990663
Front Med (Lausanne). 2021 Feb 05;8:627927
pubmed: 33614685
Int Immunopharmacol. 2019 Sep;74:105696
pubmed: 31229901
Respir Res. 2018 Feb 06;19(1):24
pubmed: 29409529
Immunity. 2015 Oct 20;43(4):803-16
pubmed: 26474656
Kidney Int Suppl (2011). 2014 Nov;4(1):34-38
pubmed: 26312148
FASEB J. 2022 Feb;36(2):e22150
pubmed: 34997943
Am J Kidney Dis. 2009 Oct;54(4):653-64
pubmed: 19615802
Annu Rev Physiol. 2017 Feb 10;79:593-617
pubmed: 27959618
Matrix Biol. 2022 Apr;108:55-76
pubmed: 35278628
Nat Commun. 2017 Oct 24;8(1):1130
pubmed: 29066712
Sci Transl Med. 2013 Jan 9;5(167):167sr1
pubmed: 23303606
Am J Physiol Cell Physiol. 2013 Apr 1;304(7):C591-603
pubmed: 23325411
J Cell Physiol. 2018 Sep;233(9):6425-6440
pubmed: 29319160
J Pathol. 2019 Aug;248(4):488-500
pubmed: 30945293
Pharmacol Res. 2016 Jun;108:57-64
pubmed: 27107790
Nat Med. 2007 Aug;13(8):952-61
pubmed: 17660828
J Immunol. 1992 Apr 15;148(8):2423-8
pubmed: 1348518
Gut. 2021 Jul;70(7):1345-1361
pubmed: 32907830
Lancet. 2020 Feb 29;395(10225):709-733
pubmed: 32061315
Int Immunopharmacol. 2019 Oct;75:105795
pubmed: 31421547
Am J Respir Cell Mol Biol. 2017 Feb;56(2):191-201
pubmed: 27668462
Clin Gastroenterol Hepatol. 2023 Apr 13;:
pubmed: 37061109
Cell Death Differ. 2021 Apr;28(4):1270-1283
pubmed: 33144678
Nephrol Dial Transplant. 2006 Jan;21(1):16-20
pubmed: 16280370
Science. 1999 Apr 30;284(5415):770-6
pubmed: 10221902
Int Immunopharmacol. 2023 Mar;116:109723
pubmed: 36696855
Drug Discov Today. 2017 Jan;22(1):186-193
pubmed: 27554801
J Clin Invest. 2005 Jan;115(1):56-65
pubmed: 15630444
Cell Death Dis. 2020 Feb 19;11(2):136
pubmed: 32075954
Am J Pathol. 2012 Apr;180(4):1398-412
pubmed: 22322297
Nature. 1997 Dec 4;390(6659):465-71
pubmed: 9393997
Cell. 2021 Dec 22;184(26):6243-6261.e27
pubmed: 34914922
Ren Fail. 2023 Dec;45(1):2149412
pubmed: 36636989
Matrix Biol. 2018 Aug;68-69:81-93
pubmed: 29408013
Dis Markers. 2022 Sep 12;2022:9883831
pubmed: 36133436
PLoS One. 2016 Nov 22;11(11):e0166808
pubmed: 27875565
Cell Death Dis. 2016 Dec 1;7(12):e2495
pubmed: 27906172
Sci Immunol. 2023 Apr 14;8(82):eadd8945
pubmed: 37027478
Cell Tissue Res. 2016 Sep;365(3):495-506
pubmed: 27461257
Biomed Pharmacother. 2020 Nov;131:110611
pubmed: 32890966
Inflammopharmacology. 2018 Apr;26(2):403-411
pubmed: 28168553
Mol Med Rep. 2015 Oct;12(4):5828-36
pubmed: 26299717
Int Immunopharmacol. 2021 Oct;99:107938
pubmed: 34371331
Front Biosci. 2008 May 01;13:6991-8
pubmed: 18508710
Pharm Biol. 2022 Dec;60(1):384-393
pubmed: 35188856
Am J Respir Crit Care Med. 2009 Oct 1;180(7):657-65
pubmed: 19556518
Nature. 2013 Apr 25;496(7446):445-55
pubmed: 23619691
Kidney Res Clin Pract. 2023 May;42(3):325-339
pubmed: 37098680
Cell Commun Signal. 2018 Nov 23;16(1):89
pubmed: 30470231
Clin Sci (Lond). 2022 May 13;136(9):643-656
pubmed: 35438166
Hepatology. 2013 Oct;58(4):1461-73
pubmed: 23553591
Steroids. 2014 Dec;91:46-53
pubmed: 24819992
Immunity. 2016 Mar 15;44(3):450-462
pubmed: 26982353
Physiol Rev. 2017 Oct 1;97(4):1235-1294
pubmed: 28794168
J Ethnopharmacol. 2022 Apr 6;287:114915
pubmed: 34954267
Am J Pathol. 2008 Dec;173(6):1617-27
pubmed: 19008372
Hepatology. 2015 Jan;61(1):303-14
pubmed: 25145286
Int J Mol Sci. 2017 Dec 29;19(1):
pubmed: 29286292
Pharmacol Res. 2022 Aug;182:106286
pubmed: 35662628
Nat Immunol. 2016 Jan;17(1):2-8
pubmed: 26681456
Front Immunol. 2021 Dec 07;12:763334
pubmed: 34950140
Arterioscler Thromb Vasc Biol. 2012 Jul;32(7):1675-86
pubmed: 22556335
JCI Insight. 2023 Mar 22;8(6):
pubmed: 36757802
J Am Soc Nephrol. 2017 Jul;28(7):2053-2067
pubmed: 28209809
Proc Natl Acad Sci U S A. 2022 Apr 12;119(15):e2121098119
pubmed: 35377803
Rheumatology (Oxford). 2018 Oct 1;57(10):1838-1850
pubmed: 29029263
Science. 2018 Nov 23;362(6417):
pubmed: 30467144

Auteurs

Huidan Yang (H)

Department of Rheumatology, Shanxi Medical University Second Affiliated Hospital, Taiyuan, Shanxi Province, China.

Hao Cheng (H)

Department of Rheumatology, Shanxi Medical University Second Affiliated Hospital, Taiyuan, Shanxi Province, China.

Rongrong Dai (R)

Department of Rheumatology, Shanxi Medical University Second Affiliated Hospital, Taiyuan, Shanxi Province, China.

Lili Shang (L)

Department of Rheumatology, Shanxi Medical University Second Affiliated Hospital, Taiyuan, Shanxi Province, China.

Xiaoying Zhang (X)

Department of Rheumatology, Shanxi Medical University Second Affiliated Hospital, Taiyuan, Shanxi Province, China.

Hongyan Wen (H)

Department of Rheumatology, Shanxi Medical University Second Affiliated Hospital, Taiyuan, Shanxi Province, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH